ERIC KLEINER Has A Pending CANNABIS SECURITIES Investor Complaint – Goodman & Nekvasil, P.A. May Recover Investor Losses
MORGAN STANLEY investment adviser, ERIC KLEINER Has A Pending CANNABIS SECURITIES Investor Complaint.
Update: 11/17/25 – Kleiner Consents to a FINRA Bar
Without admitting or denying the findings, Kleiner consented to the sanction and to the entry of findings that he refused to provide documents and information requested by FINRA during an investigation that originated from its review of the Form U5 filed by his member firm. The finding stated that the firm filed the Form U5 stating that it discharged Kleiner due to concerns related to his recommendation of non-firm approved and firm restricted investments to customers, including ones in which he was also invested, failure to fully disclose outside investment, and use of a personal device to engage in unauthorized disclosure of confidential, internal use only firm information.
ERIC KLEINER
CRD#: 4135180
Call 800-500-4442 if you purchased investments in TerrAscend Corp. and experienced losses.
ERIC BRIAN KLEINER (CRD#: 4135180), a registered representative for MORGAN STANLEY in New York, NY, has a pending CANNABIS SECURITIES Investor Complaint. Goodman & Nekvasil, P.A. is representing customers of Kleiner who have significant losses from purchasing TerrAscend Corp., a North American cannabis company.
Kleiner’s pending investor complaint is demanding $300,000.00. The claimant ALLEGED RECOMMENDATIONS TO INVEST IN CANNABIS SECURITIES WERE UNSUITABLE FOR SOMEONE HIS AGE 2021.
ERIC KLEINER Has A Pending CANNABIS SECURITIES Investor Complaint.
Goodman & Nekvasil, P.A., is investigating brokers who may have unsuitably recommended investments to their clients.
St. Petersburg, Florida law firm Goodman & Nekvasil, P.A., has a national practice representing victimized investors. The firm continues to investigate brokerage firms that placed elderly retirees and other conservative investors in unsuitable investments.
Goodman & Nekvasil, P.A., has filed numerous cases against brokerage firms selling high-risk investments and has recovered more than $400 million dollars on behalf of victimized investors.
We allege in these cases that these investment recommendations were unsuitable for our clients in view of their financial situation, needs and investment objectives.
There is no charge for an evaluation of your case. We handle our cases on a contingency fee basis. This means that unless we recover money for you, we charge no attorney’s fee.
If you incurred losses on your investment and would like your case evaluated by a securities attorney, please contact us.
Some of the information in this blog post was obtained from FINRA on 11/12/24. If you believe this information was reported incorrectly, please contact our firm: 1-800-500-4442.